Trial
NCT02371590
Lenalidomide and Obinutuzumab for Previously Untreated CLL
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, San Diego
Collaborators
Celgene Corporation; Genentech, Inc.
Condition
Chronic Lymphocytic Leukemia
Intervention
Lenalidomide
Why stopped
Study Not Activated Due to Contract Issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-23